Active Ingredient(s): Acetohydroxamic Acid
FDA Approved: * May 31, 1983
Pharm Company: * MISSION PHARMA
Category: Urinary System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Lithostat Overview

Acetohydroxamic acid (also known as AHA or by the trade name Lithostat) is a drug that is a potent and irreversible enzyme inhibitor of the urease enzyme in various bacteria and plants; it is usually used for urinary tract infections. The molecule is similar to urea but is not hydrolyzable by urease;[1] it thus disrupts the bacteria's metabolism through competitive inhibition. Orphan drug In 1983 the US Food and Drug Administration approved acetohydroxamic acid (AHA) as an ...

Read more Lithostat Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Lithostat Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Acetohydroxamic Acid
  • Tablet: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lithostat: (1 result)

Sorted by National Drug Code
  • 0178-0500 Lithostat 250 mg Oral Tablet by Mission Pharmacal Company

Other drugs which contain Acetohydroxamic Acid or a similar ingredient: (1 result)